Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 44

    1.

    Adherence remains a challenge for patients receiving growth hormone therapy.

    Norgren S.

    Pediatr Endocrinol Rev. 2009 Jun;6 Suppl 4:545-8. Review.PMID: 19550391 [PubMed - indexed for MEDLINE]Related articles

    2.

    Genetic variance in the adiponutrin gene family and childhood obesity.

    Johansson LE, Johansson LM, Danielsson P, Norgren S, Johansson S, Marcus C, Ridderstråle M.

    PLoS One. 2009;4(4):e5327. Epub 2009 Apr 24.PMID: 19390624 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Variations in incidence of type 1 diabetes in different municipalities of stockholm.

    Gopinath S, Ortqvist E, Norgren S, Green A, Sanjeevi CB.

    Ann N Y Acad Sci. 2008 Dec;1150:200-7.PMID: 19120295 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insulin sensitivity, VO2max and body composition in severely obese Swedish children and adolescents.

    Morinder G, Larsson UE, Norgren S, Marcus C.

    Acta Paediatr. 2009 Jan;98(1):132-8. Epub 2008 Sep 19.PMID: 18808398 [PubMed - indexed for MEDLINE]Related articles

    5.

    Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity.

    Johansson LE, Danielsson P, Norgren S, Marcus C, Ridderstråle M.

    Int J Pediatr Obes. 2009;4(2):119-25.PMID: 18645733 [PubMed - indexed for MEDLINE]Related articles

    6.

    Alternative methods of insulin sensitivity assessment in obese children and adolescents.

    Rössner SM, Neovius M, Montgomery SM, Marcus C, Norgren S.

    Diabetes Care. 2008 Apr;31(4):802-4. Epub 2008 Jan 17.PMID: 18202247 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes.

    Danielsson P, Janson A, Norgren S, Marcus C.

    J Clin Endocrinol Metab. 2007 Nov;92(11):4101-6. Epub 2007 Aug 28.PMID: 17726084 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Type 1 diabetic serum interferes with pancreatic beta-cell Ca2+-handling.

    Dekki N, Nilsson R, Norgren S, Rössner SM, Appelskog I, Marcus C, Simell O, Pugliese A, Alejandro R, Ricordi C, Berggren PO, Juntti-Berggren L.

    Biosci Rep. 2007 Dec;27(6):321-6.PMID: 17597394 [PubMed - indexed for MEDLINE]Related articles

    9.

    Transthyretin constitutes a functional component in pancreatic beta-cell stimulus-secretion coupling.

    Refai E, Dekki N, Yang SN, Imreh G, Cabrera O, Yu L, Yang G, Norgren S, Rössner SM, Inverardi L, Ricordi C, Olivecrona G, Andersson M, Jörnvall H, Berggren PO, Juntti-Berggren L.

    Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17020-5. Epub 2005 Nov 14.PMID: 16286652 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Lack of mutations in the TSHr and Gsalpha genes in TSHr antibody negative Graves' disease.

    Elgadi A, Frisk T, Larsson C, Wallin G, Höög A, Zedenius J, Norgren S.

    Exp Clin Endocrinol Diabetes. 2005 Oct;113(9):516-21.PMID: 16235153 [PubMed - indexed for MEDLINE]Related articles

    11.

    Autosomal-dominant non-autoimmune hyperthyroidism presenting with neuromuscular symptoms.

    Elgadi A, Arvidsson CG, Janson A, Marcus C, Costagliola S, Norgren S.

    Acta Paediatr. 2005 Aug;94(8):1145-8.PMID: 16188864 [PubMed - indexed for MEDLINE]Related articles

    12.

    Physiological and pathological aspects of GSH metabolism.

    Njålsson R, Norgren S.

    Acta Paediatr. 2005 Feb;94(2):132-7. Review.PMID: 15981742 [PubMed - indexed for MEDLINE]Related articles

    13.

    Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency.

    Njålsson R, Ristoff E, Carlsson K, Winkler A, Larsson A, Norgren S.

    Hum Genet. 2005 Apr;116(5):384-9. Epub 2005 Feb 17.PMID: 15717202 [PubMed - indexed for MEDLINE]Related articles

    14.

    Age-dependent regulation of lipogenesis in human and rat adipocytes.

    Kamel AF, Norgren S, Strigård K, Thörne A, Fakhrai-Rad H, Galli J, Marcus C.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4601-6.PMID: 15356069 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Human hereditary glutathione synthetase deficiency: kinetic properties of mutant enzymes.

    Njålsson R, Carlsson K, Bhansali V, Luo JL, Nilsson L, Ladenstein R, Anderson M, Larsson A, Norgren S.

    Biochem J. 2004 Jul 15;381(Pt 2):489-94.PMID: 15056072 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Clinical, histopathologic, and genetic investigation in two large families with dentinogenesis imperfecta type II.

    Malmgren B, Lindskog S, Elgadi A, Norgren S.

    Hum Genet. 2004 Apr;114(5):491-8. Epub 2004 Feb 3.PMID: 14758537 [PubMed - indexed for MEDLINE]Related articles

    17.

    Diagnostics in patients with glutathione synthetase deficiency but without mutations in the exons of the GSS gene.

    Njålsson R, Carlsson K, Winkler A, Larsson A, Norgren S.

    Hum Mutat. 2003 Dec;22(6):497.PMID: 14635114 [PubMed - indexed for MEDLINE]Related articles

    18.

    Orlistat treatment in obese prepubertal children: a pilot study.

    Norgren S, Danielsson P, Jurold R, Lötborn M, Marcus C.

    Acta Paediatr. 2003 Jun;92(6):666-70.PMID: 12856974 [PubMed - indexed for MEDLINE]Related articles

    19.

    Glutathione synthetase deficiency: is gamma-glutamylcysteine accumulation a way to cope with oxidative stress in cells with insufficient levels of glutathione?

    Ristoff E, Hebert C, Njålsson R, Norgren S, Rooyackers O, Larsson A.

    J Inherit Metab Dis. 2002 Nov;25(7):577-84.PMID: 12638941 [PubMed - indexed for MEDLINE]Related articles

    20.

    Dental aberrations in children and adolescents with osteogenesis imperfecta.

    Malmgren B, Norgren S.

    Acta Odontol Scand. 2002 Mar;60(2):65-71.PMID: 12020117 [PubMed - indexed for MEDLINE]Related articles

    21.

    The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome.

    Santer R, Groth S, Kinner M, Dombrowski A, Berry GT, Brodehl J, Leonard JV, Moses S, Norgren S, Skovby F, Schneppenheim R, Steinmann B, Schaub J.

    Hum Genet. 2002 Jan;110(1):21-9. Epub 2001 Nov 17.PMID: 11810292 [PubMed - indexed for MEDLINE]Related articles

    22.

    Cooperative binding of gamma-glutamyl substrate to human glutathione synthetase.

    Njalsson R, Norgren S, Larsson A, Huang CS, Anderson ME, Luo JL.

    Biochem Biophys Res Commun. 2001 Nov 23;289(1):80-4.PMID: 11708780 [PubMed - indexed for MEDLINE]Related articles

    23.

    Effects of growth hormone treatment on the leptin system and body composition in obese prepubertal boys.

    Elimam A, Norgren S, Marcus C.

    Acta Paediatr. 2001 May;90(5):520-5.PMID: 11430711 [PubMed - indexed for MEDLINE]Related articles

    24.

    Total parenteral nutrition after surgery rapidly increases serum leptin levels.

    Elimam A, Tjäder I, Norgren S, Wernerman J, Essen P, Ljungqvist O, Marcus C.

    Eur J Endocrinol. 2001 Feb;144(2):123-8.PMID: 11182748 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats.

    Fakhrai-Rad H, Nikoshkov A, Kamel A, Fernström M, Zierath JR, Norgren S, Luthman H, Galli J.

    Hum Mol Genet. 2000 Sep 1;9(14):2149-58.PMID: 10958757 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Kinetic properties of missense mutations in patients with glutathione synthetase deficiency.

    Njålsson R, Carlsson K, Olin B, Carlsson B, Whitbread L, Polekhina G, Parker MW, Norgren S, Mannervik B, Board PG, Larsson A.

    Biochem J. 2000 Jul 1;349(Pt 1):275-9.PMID: 10861239 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Effects of growth hormone treatment in obese prepubertal boys.

    Kamel A, Norgren S, Elimam A, Danielsson P, Marcus C.

    J Clin Endocrinol Metab. 2000 Apr;85(4):1412-9.PMID: 10770175 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Growth hormone treatment downregulates serum leptin levels in children independent of changes in body mass index.

    Elimam A, Lindgren AC, Norgren S, Kamel A, Skwirut C, Bang P, Marcus C.

    Horm Res. 1999;52(2):66-72.PMID: 10681635 [PubMed - indexed for MEDLINE]Related articles

    29.

    Pathophysiological and genetic characterization of the major diabetes locus in GK rats.

    Galli J, Fakhrai-Rad H, Kamel A, Marcus C, Norgren S, Luthman H.

    Diabetes. 1999 Dec;48(12):2463-70.PMID: 10580437 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Insulin induced hypoglycaemia: comparison of glucose and glycerol concentrations in plasma and microdialysate from subcutaneous adipose tissue.

    Kamel A, Norgren S, Persson B, Marcus C.

    Arch Dis Child. 1999 Jan;80(1):42-5.PMID: 10325757 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Changes in cytoplasmic ATP concentration parallels changes in ATP-regulated K+-channel activity in insulin-secreting cells.

    Köhler M, Norgren S, Berggren PO, Fredholm BB, Larsson O, Rhodes CJ, Herbert TP, Luthman H.

    FEBS Lett. 1998 Dec 11;441(1):97-102.PMID: 9877173 [PubMed - indexed for MEDLINE]Related articles

    32.

    Effect of growth hormone treatment on insulin action in adipocytes from children with Prader-Willi syndrome.

    Kamel A, Norgren S, Lindgren AC, Luthman H, Arner P, Marcus C.

    Eur J Endocrinol. 1998 May;138(5):510-6.PMID: 9625361 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Antilipolytic effect of insulin and insulin receptor messenger RNA expression in adipocytes of infants, children, and adults.

    Kamel A, Norgren S, Ehrén H, Hildingsson U, Marcus C.

    Pediatr Res. 1997 Apr;41(4 Pt 1):563-7.PMID: 9098861 [PubMed - indexed for MEDLINE]Related articles

    34.

    B cells of aging rats: impaired stimulus-secretion coupling but normal susceptibility to adverse effects of a diabetic state.

    Inoue K, Norgren S, Luthman H, Möller C, Grill V.

    Metabolism. 1997 Mar;46(3):242-6.PMID: 9054463 [PubMed - indexed for MEDLINE]Related articles

    35.

    Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains.

    Johnston JA, Norgren S, Ravid R, Wasco W, Winblad B, Lannfelt L, Cowburn RF.

    Brain Res Mol Brain Res. 1996 Dec 31;43(1-2):85-95.PMID: 9037522 [PubMed - indexed for MEDLINE]Related articles

    36.

    A new quantitative solution hybridisation-RNase protection assay for APP and APLP2 mRNA.

    Johnston JA, Norgren S, Annerén G, Cowburn RF, Lannfelt L.

    Brain Res Mol Brain Res. 1996 Dec 31;43(1-2):77-84.PMID: 9037521 [PubMed - indexed for MEDLINE]Related articles

    37.

    Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation.

    Johnston JA, Cowburn RF, Norgren S, Wiehager B, Venizelos N, Winblad B, Vigo-Pelfrey C, Schenk D, Lannfelt L, O'Neill C.

    FEBS Lett. 1994 Nov 14;354(3):274-8.PMID: 7957938 [PubMed - indexed for MEDLINE]Related articles

    38.

    Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells.

    Vitols S, Norgren S, Juliusson G, Tatidis L, Luthman H.

    Blood. 1994 Oct 15;84(8):2689-98.PMID: 7919382 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Insulin receptor ribonucleic acid levels and alternative splicing in human liver, muscle, and adipose tissue: tissue specificity and relation to insulin action.

    Norgren S, Arner P, Luthman H.

    J Clin Endocrinol Metab. 1994 Mar;78(3):757-62.PMID: 7510306 [PubMed - indexed for MEDLINE]Related articles

    40.

    Regulation of human insulin receptor RNA splicing in HepG2 cells: effects of glucocorticoid and low glucose concentration.

    Norgren S, Li LS, Luthman H.

    Biochem Biophys Res Commun. 1994 Feb 28;199(1):277-84.PMID: 8123024 [PubMed - indexed for MEDLINE]Related articles

    41.

    Regulation of human insulin receptor RNA splicing in vivo.

    Norgren S, Zierath J, Wedell A, Wallberg-Henriksson H, Luthman H.

    Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1465-9.PMID: 8108432 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Differences in the ratio of RNA encoding two isoforms of the insulin receptor between control and NIDDM patients. The RNA variant without Exon 11 predominates in both groups.

    Norgren S, Zierath J, Galuska D, Wallberg-Henriksson H, Luthman H.

    Diabetes. 1993 May;42(5):675-81.PMID: 7683288 [PubMed - indexed for MEDLINE]Related articles

    43.

    Molecular genetics of NIDDM and the genes for insulin and insulin receptor.

    Luthman H, Delin I, Glaser A, Luft R, Norgren S, Wedell A.

    Adv Exp Med Biol. 1993;334:101-11. Review. No abstract available. PMID: 8249676 [PubMed - indexed for MEDLINE]Related articles

    44.

    Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.

    Gruber A, Vitols S, Norgren S, Areström I, Peterson C, Björkholm M, Reizenstein P, Luthman H.

    Br J Cancer. 1992 Aug;66(2):266-72.PMID: 1380280 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...